These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1603628)

  • 1. Allogenic bone marrow transplantation in severe Gaucher disease.
    Tsai P; Lipton JM; Sahdev I; Najfeld V; Rankin LR; Slyper AH; Ludman M; Grabowski GA
    Pediatr Res; 1992 May; 31(5):503-7. PubMed ID: 1603628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone-marrow transplantation in severe Gaucher's disease.
    Rappeport JM; Ginns EI
    N Engl J Med; 1984 Jul; 311(2):84-8. PubMed ID: 6377066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical studies in a patient with subacute neuropathic Gaucher disease without visceral glucosylceramide storage.
    Wenger DA; Roth S; Kudoh T; Grover WD; Tucker SH; Kaye EM; Ullman MD
    Pediatr Res; 1983 May; 17(5):344-8. PubMed ID: 6856396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaucher's disease.
    Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahasrabudhe GS; Chole PV
    J Assoc Physicians India; 2009 May; 57():410-1. PubMed ID: 19634291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease.
    Wells S; Malik P; Pensiero M; Kohn DB; Nolta JA
    Gene Ther; 1995 Oct; 2(8):512-20. PubMed ID: 8593601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten years' experience of bone marrow transplantation for Gaucher disease.
    Ringdén O; Groth CG; Erikson A; Granqvist S; Månsson JE; Sparrelid E
    Transplantation; 1995 Mar; 59(6):864-70. PubMed ID: 7701581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norrbottnian type of Gaucher disease--clinical, biochemical and molecular biology aspects: successful treatment with bone marrow transplantation.
    Svennerholm L; Erikson A; Groth CG; Ringdén O; Månsson JE
    Dev Neurosci; 1991; 13(4-5):345-51. PubMed ID: 1817041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation in Gaucher's disease: effect of mixed chimeric state.
    Chan KW; Wong LT; Applegarth D; Davidson AG
    Bone Marrow Transplant; 1994 Aug; 14(2):327-30. PubMed ID: 7994251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease.
    McEachern KA; Nietupski JB; Chuang WL; Armentano D; Johnson J; Hutto E; Grabowski GA; Cheng SH; Marshall J
    J Gene Med; 2006 Jun; 8(6):719-29. PubMed ID: 16528760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment.
    Erikson A
    Acta Paediatr Scand Suppl; 1986; 326():1-42. PubMed ID: 3296644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells in patients with type I Gaucher disease are decreased in number but functionally normal.
    Micheva I; Marinakis T; Repa C; Kouraklis-Symeonidis A; Vlacha V; Anagnostopoulos N; Zoumbos N; Symeonidis A
    Blood Cells Mol Dis; 2006; 36(2):298-307. PubMed ID: 16533613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.
    Mizukami H; Mi Y; Wada R; Kono M; Yamashita T; Liu Y; Werth N; Sandhoff R; Sandhoff K; Proia RL
    J Clin Invest; 2002 May; 109(9):1215-21. PubMed ID: 11994410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced calcium release in the acute neuronopathic form of Gaucher disease.
    Pelled D; Trajkovic-Bodennec S; Lloyd-Evans E; Sidransky E; Schiffmann R; Futerman AH
    Neurobiol Dis; 2005 Feb; 18(1):83-8. PubMed ID: 15649698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow.
    Nolta JA; Yu XJ; Bahner I; Kohn DB
    J Clin Invest; 1992 Aug; 90(2):342-8. PubMed ID: 1379609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J; Szücs FZ; Benkö K; Maródi L
    Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
    Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
    FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
    Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocerebroside storage in normal monocyte cultures.
    Hardy B; Teitelman-Weissman B; Chazan S; Neri A
    Biomed Pharmacother; 1987; 41(1):40-4. PubMed ID: 3607254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation for genetic and metabolic disorders.
    Schaison G; Bordigoni P; Leverger G
    Nouv Rev Fr Hematol (1978); 1989; 31(2):119-23. PubMed ID: 2505227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attempt at enzyme replacement by organ transplantation: renal transplantation in Gaucher disease.
    Groth CG; Collste H; Dreborg S; Håkansson G; Lundgren G; Svennerholm L
    Transplant Proc; 1979 Jun; 11(2):1218-9. PubMed ID: 382486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.